Try our Advanced Search for more refined results
Lupin Ltd.
-
Minutes | Filed: February 07, 2023 | Entered: February 07, 2023 Astellas Pharma Inc. et al v. Sandoz Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Bench Trial - Held
Minute Entry for Day 2 of a Bench Trial held before Judge Joseph F. Bataillon - Bench Trial held on 2/7/2023. (Court Reporter Dale Hawkins.) (apk)
-
Misc | Filed: February 07, 2023 | Entered: February 07, 2023 Neurocrine Biosciences, Inc. v. Lupin Limited et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Letter
Letter to The Honorable Maryellen Noreika from Stephen B. Brauerman regarding Defendants' Joint Answering Letter Concerning Narrowing Dispute (D.I. 135) - re 135 Order Setting Teleconference,,. (Brauerman, Stephen)
-
Misc | Filed: February 07, 2023 | Entered: February 07, 2023 Neurocrine Biosciences, Inc. v. Lupin Limited et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Letter
Letter to The Honorable Maryellen Noreika from Steven J. Balick regarding Neurocrine's Answering Letter Concerning Streamlining of Issues for Trial. (Attachments: # 1 Exhibit D-E)(Balick, Steven)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login